Virtu Financial’s Phio Pharmaceuticals PHIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34K | Buy |
+14,298
| New | +$34K | ﹤0.01% | 1189 |
|
2025
Q1 | – | Sell |
-40,910
| Closed | -$74K | – | 1883 |
|
2024
Q4 | $74K | Buy |
+40,910
| New | +$74K | ﹤0.01% | 1087 |
|
2024
Q2 | – | Sell |
-3,435
| Closed | -$21K | – | 1755 |
|
2024
Q1 | $21K | Buy |
3,435
+1,319
| +62% | +$8.06K | ﹤0.01% | 1159 |
|
2023
Q4 | $14K | Buy |
+2,116
| New | +$14K | ﹤0.01% | 1373 |
|
2022
Q4 | – | Sell |
-180
| Closed | -$11K | – | 2023 |
|
2022
Q3 | $11K | Buy |
180
+38
| +27% | +$2.32K | ﹤0.01% | 1509 |
|
2022
Q2 | $11K | Sell |
142
-253
| -64% | -$19.6K | ﹤0.01% | 1418 |
|
2022
Q1 | $38K | Sell |
395
-65
| -14% | -$6.25K | ﹤0.01% | 1196 |
|
2021
Q4 | $50K | Buy |
460
+39
| +9% | +$4.24K | 0.01% | 1343 |
|
2021
Q3 | $92K | Buy |
421
+170
| +68% | +$37.2K | 0.01% | 1167 |
|
2021
Q2 | $61K | Buy |
251
+107
| +74% | +$26K | 0.01% | 1303 |
|
2021
Q1 | $42K | Buy |
+144
| New | +$42K | ﹤0.01% | 1453 |
|
2020
Q4 | – | Sell |
-333
| Closed | -$77K | – | 1712 |
|
2020
Q3 | $77K | Buy |
+333
| New | +$77K | 0.01% | 757 |
|
2019
Q4 | $17K | Buy |
+16
| New | +$17K | ﹤0.01% | 1338 |
|
2019
Q2 | – | Sell |
-40
| Closed | -$107K | – | 1740 |
|
2019
Q1 | $107K | Buy |
+40
| New | +$107K | 0.01% | 1106 |
|
2018
Q3 | – | Sell |
-2
| Closed | -$23K | – | 2018 |
|
2018
Q2 | $23K | Sell |
2
-2
| -50% | -$23K | ﹤0.01% | 1843 |
|
2018
Q1 | $67K | Buy |
+4
| New | +$67K | ﹤0.01% | 1656 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 2246 |
|